Thomas Reiberger

2008–2026 年に発表

223
論文数
19,034
被引用数
73
h 指数
197
i10 指数

被引用数

Thomas Reiberger の年別被引用数1984 年: 被引用 7 件1996 年: 被引用 1 件2010 年: 被引用 1 件2011 年: 被引用 5 件2012 年: 被引用 8 件2013 年: 被引用 13 件2014 年: 被引用 32 件2015 年: 被引用 52 件2016 年: 被引用 66 件2017 年: 被引用 78 件2018 年: 被引用 70 件2019 年: 被引用 315 件2020 年: 被引用 504 件2021 年: 被引用 649 件2022 年: 被引用 738 件2023 年: 被引用 844 件2024 年: 被引用 1,543 件2025 年: 被引用 914 件2026 年: 被引用 25 件1985〜1995 年は被引用が無いため表示していません1997〜2009 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図中国: 引用元論文 972 件、この内訳の 14%アメリカ合衆国: 引用元論文 918 件、この内訳の 13.2%イタリア: 引用元論文 513 件、この内訳の 7.4%ドイツ: 引用元論文 458 件、この内訳の 6.6%イギリス: 引用元論文 405 件、この内訳の 5.8%スペイン: 引用元論文 400 件、この内訳の 5.7%オーストリア: 引用元論文 327 件、この内訳の 4.7%フランス: 引用元論文 295 件、この内訳の 4.2%スイス: 引用元論文 200 件、この内訳の 2.9%カナダ: 引用元論文 179 件、この内訳の 2.6%日本: 引用元論文 169 件、この内訳の 2.4%インド: 引用元論文 158 件、この内訳の 2.3%
0%14%その他 28.2%

分野

  • Medicine80%
  • Biochemistry, Genetics and Molecular Biology8.2%
  • Environmental Science5.4%
  • Immunology and Microbiology3.3%
  • Engineering0.8%
  • Nursing0.5%
  • その他1.8%

トピック

  • Liver Disease Diagnosis and Treatment15.3%
  • Liver Disease and Transplantation14.4%
  • Hepatocellular Carcinoma Treatment and Prognosis5.5%
  • Organ Transplantation Techniques and Outcomes4.2%
  • Hepatitis C virus research2.5%
  • Cancer Immunotherapy and Biomarkers2.4%
  • その他55.7%

共著者

全論文

検索で開く
  1. Baveno VII – Renewing consensus in portal hypertension

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jidong Jia, Jean‐Jacques Kiladjian, Aleksander Krag, Wim Laleman, Vincenzo La Mura, Sabela Lens, Xuefeng Luo, Mattias Mandorfer, Sarwa Darwish Murad, Valérie Paradis, David Patch, Salvatore Piano, Massimo Pinzani, Aurélie Plessier, Massimo Primignani, Bogdan Procopeț, Pierre‐Emmanuel Rautou, Marika Rudler, Shiv Kumar Sarin, Filippo Schepis, Marco Senzolo, Vijay H. Shah, Akash Shukla, Puneeta Tandon, Luís Téllez, Dominique Thabut, Maja Thiele, Jonel Trebicka, Dhiraj Tripathi, Emmanouil Tsochatzis, Laura Turco, Fanny Turón, Dominique Valla, Càndid Villanueva, Ian R. Wanless, Hitoshi Yoshiji - Journal of Hepatology 2021 被引用: 2,669

  2. The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Cristina Solé, Germán Soriano, Andrea De Gottardi, Henning Grønbæk, Faouzi Saliba, Christian Trautwein, Osman Özdoğan, Sven Francque, Stephen Ryder, Pierre Nahon, Manuel Romero‐Gómez, Hans Van Vlierberghe, Claire Francoz, Michael P. Manns, Elisabet García, Manuel Tufoni, Àlex Amorós, Marco Pavesi, Cristina Sánchez, Anna Curto, Carla Pitarch, Antonella Putignano, Esau Moreno, Debbie L. Shawcross, Ferrán Aguilar, Joan Clària, Paola Ponzo, Christian Jansen, Zsuzsanna Vitális, Giacomo Zaccherini, Boglárka Balogh, Vı́ctor Vargas, Sara Montagnese, Carlo Alessandria, Mauro Bernardi, Pere Ginès, Rajiv Jalan, Richard Moreau, Paolo Angeli, Vicente Arroyo, Miriam Maschmeier, David Semela, Laure Elkrief, Ahmed M. Elsharkawy, Tamás Tornai, István Tornai, I Altorjay, Agnese Antognoli, Maurizio Baldassarre, Martina Gagliardi, Eleonora Bertoli, Sara Mareso, Alessandra Brocca, Daniela Campion, Giorgio Maria Saracco, Martina Rizzo, Jennifer Lehmann, Alessandra Pohlmann, Michael Praktiknjo, Robert Schierwagen, Elsa Solà, Nesrine Amari, Miguel Rodriguez, Frederik Nevens, Ana Clemente, Peter Jarčuška, Alexander L. Gerbes, Mattias Mandorfer, Christoph Welsch, Emanuela Ciracì ほか 26 名 - Journal of Hepatology 2020 被引用: 504

  3. Detection of Various Microplastics in Human Stool

    著者: , , , , , , - Annals of Internal Medicine 2019 被引用: 1,877

  4. Prognosis of patients with hepatocellular carcinoma treated with immunotherapy – development and validation of the CRAFITY score

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michael Trauner, Nicola Personeni, Lorenza Rimassa, Michael Bitzer, Jörg Trojan, Arndt Weinmann, Henning Wege, Jean‐François Dufour, Markus Peck‐Radosavljevic, Arndt Vogel, Matthias Pinter - Journal of Hepatology 2021 被引用: 300

  5. Noninvasive Diagnosis of Portal Hypertension in Patients With Compensated Advanced Chronic Liver Disease

    著者: , , , , , , , , , , , , , , , , , , , , - The American Journal of Gastroenterology 2020 被引用: 243

  6. Diet and exercise in NAFLD/NASH: Beyond the obvious

    著者: , , , - Liver International 2021 被引用: 178

  7. CXCR4 inhibition in tumor microenvironment facilitates anti‐programmed death receptor‐1 immunotherapy in sorafenib‐treated hepatocellular carcinoma in mice

    著者: , , , , , , , , , , , , , , , - Hepatology 2014 被引用: 458

  8. Inflammasomes in chronic liver disease: Hepatic injury, fibrosis progression and systemic inflammation

    著者: , , , - Journal of Hepatology 2024 被引用: 266

  9. Systemic inflammation increases across distinct stages of advanced chronic liver disease and correlates with decompensation and mortality

    著者: , , , , , , , , , , , , - Journal of Hepatology 2020 被引用: 202

  10. Dynamics in Liver Stiffness Measurements Predict Outcomes in Advanced Chronic Liver Disease

    著者: , , , , , , , , , , , , , , , , , , - Gastroenterology 2023 被引用: 95

  11. PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , José Presa Ramos, Cristina Solé, Germán Soriano, Andrea De Gottardi, Henning Grønbæk, Faouzi Saliba, Christian Trautwein, Haluk Tarık Kani, Sven Francque, Stephen Ryder, Pierre Nahon, Manuel Romero‐Gómez, Hans Van Vlierberghe, Claire Francoz, Michael P. Manns, Elisabet García, Manuel Tufoni, Àlex Amorós, Marco Pavesi, Cristina Sánchez, Michael Praktiknjo, Anna Curto, Carla Pitarch, Antonella Putignano, Esau Moreno, William Bernal, Ferrán Aguilar, Joan Clària, Paola Ponzo, Zsuzsanna Vitális, Giacomo Zaccherini, Boglárka Balogh, Alexander L. Gerbes, Vı́ctor Vargas, Carlo Alessandria, Mauro Bernardi, Pere Ginès, Richard Moreau, Paolo Angeli, Rajiv Jalan, Vicente Arroyo, Miriam Maschmeier, David Semela, Laure Elkrief, Ahmed M. Elsharkawy, Tamás Tornai, István Tornai, I Altorjay, Agnese Antognoli, Maurizio Baldassarre, Martina Gagliardi, Eleonora Bertoli, Sara Mareso, Alessandra Brocca, Daniela Campion, Giorgio Maria Saracco, Martina Rizzo, Jennifer Lehmann, Alessandra Pohlmann, Maximilian Joseph Brol, Johannes Chang, Robert Schierwagen, Elsa Solà, Nesrine Amari, Miguel Ángel Morán Rodríguez, Frederik Nevens, Ana Clemente, Martin Janíčko, Daniel Markwardt, Mattias Mandorfer ほか 29 名 - Journal of Hepatology 2020 被引用: 288

  12. Accuracy of spleen stiffness measurement for the diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a systematic review and individual patient data meta-analysis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Yoichi Hias, A. Fichera, Chin Chin Ooi, Alberto Borghi, David Bauer, Georg Semmler, Mattias Mandorfer, José Luís Calleja, Omar Elshaarawy, Dante Romagnoli - ˜The œLancet. Gastroenterology & hepatology 2023 被引用: 89

  13. Alcohol Abstinence Improves Prognosis Across All Stages of Portal Hypertension in Alcohol-Related Cirrhosis

    著者: , , , , , , , , , , , , , - Clinical Gastroenterology and Hepatology 2022 被引用: 122

  14. The FXR agonist PX20606 ameliorates portal hypertension by targeting vascular remodelling and sinusoidal dysfunction

    著者: , , , , , , , , , , , , , , , , , , , - Journal of Hepatology 2016 被引用: 171

  15. Bile acid metabolism and signalling in liver disease

    著者: , , , , , - Journal of Hepatology 2024 被引用: 167

  16. Severity of systemic inflammation is the main predictor of ACLF and bleeding in individuals with acutely decompensated cirrhosis

    著者: , , , , , , , , , , , , , , , - Journal of Hepatology 2022 被引用: 99

  17. WFUMB Guidelines/Guidance on Liver Multiparametric Ultrasound. Part 2: Guidance on Liver Fat Quantification

    著者: , , , , , , , , , , , , , , , , - Ultrasound in Medicine & Biology 2024 被引用: 111

  18. Hepatic recompensation according to Baveno VII criteria is linked to a significant survival benefit in decompensated alcohol‐related cirrhosis

    著者: , , , , , , , , , , , - Liver International 2023 被引用: 87

  19. Non-invasive tests for clinically significant portal hypertension after HCV cure

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jaime Bosch, Juan Carlos García‐Pagán, Mattias Mandorfer - Journal of Hepatology 2022 被引用: 84

  20. Anticoagulation improves survival in patients with cirrhosis and portal vein thrombosis: The IMPORTAL competing-risk meta-analysis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Hepatology 2023 被引用: 117

  21. Austrian consensus on the diagnosis and management of portal hypertension in advanced chronic liver disease (Billroth IV)

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Wiener klinische Wochenschrift 2023 被引用: 61

  22. HCC risk stratification after cure of hepatitis C in patients with compensated advanced chronic liver disease

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Hepatology 2021 被引用: 133

  23. The Value of Liver and Spleen Stiffness for Evaluation of Portal Hypertension in Compensated Cirrhosis

    著者: - Hepatology Communications 2021 被引用: 125

  24. TIPS prevents further decompensation and improves survival in patients with cirrhosis and portal hypertension in an individual patient data meta-analysis

    著者: , , , , , , , , , , , , , , - Journal of Hepatology 2023 被引用: 109